DeLorean AI is targeting Chronic Kidney Disease by using precision predictive analytics to spot renal decline years before ...
The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...
Akebia Therapeutics has decided not to initiate a clinical trial assessing vadadustat in patients with late-stage CKD not on dialysis.
The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback